NCT03521700View on ClinicalTrials.gov

Compare Effects of Intensive Versus Conventional Lipid-lowering Therapy in Patients With Severe Atherosclerotic Renal Artery Stenosis Undergoing Stent Placement

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

June 1, 2013

Primary Completion Date

December 30, 2014

Study Completion Date

December 30, 2015

Conditions

Renal Artery ObstructionStentsLipidsGlomerular Filtration RateBlood Pressure

Interventions

DRUG

Rosuvastatin

For patients who were assigned to receive intensive lipid lowering, 10 mg/d rosuvastatin was initially prescribed and target LDL-C was \< 1.8mmol/L. For patients who were assigned to receive conventional lipid lowering, 5 mg/d rosuvastatin was initially prescribed and target LDL-C was ≥1.8mmol/L, \<3.3mmol/L.

Trial Locations (1)

010

Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing

All Listed Sponsors

lead

Chinese Academy of Medical Sciences, Fuwai Hospital

OTHER

NCT03521700 - Compare Effects of Intensive Versus Conventional Lipid-lowering Therapy in Patients With Severe Atherosclerotic Renal Artery Stenosis Undergoing Stent Placement | Biotech Hunter | Biotech Hunter